BMY vs PKE · P/E 17, rev $24.46B vs P/E 51, rev $73.3M
Bristol-Myers Squibb Company (BMY) versus Park Electrochemical Corporation (PKE) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Park Electrochemical Corporation (PKE) is a aerospace & defense company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported PKE revenue for 2026-03-01 was $73.3M. Net income was $11.3M. Revenue was up 18.2% from 2025-03-02 to 2026-03-01. PKE currently screens at market cap $291.2M and trailing P/E 50.6.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. PKE currently screens at market cap $291.2M and trailing P/E 50.6.
Not investment advice. Open the BMY and PKE stock pages for the full models.
Not investment advice.